Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Sells $36,582.15 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Amy L. Ladd sold 55 shares of the company’s stock in a transaction that occurred on Friday, July 24th. The shares were sold at an average price of $665.13, for a total value of $36,582.15. Following the transaction, the director now owns 128 shares of the company’s stock, valued at approximately $85,136.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Intuitive Surgical stock opened at $695.79 on Thursday. The stock has a market cap of $81.39 billion, a price-to-earnings ratio of 73.16, a price-to-earnings-growth ratio of 11.86 and a beta of 0.93. The stock has a 50 day moving average price of $597.24 and a 200-day moving average price of $553.83. Intuitive Surgical, Inc. has a one year low of $360.50 and a one year high of $704.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 21st. The medical equipment provider reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.52. Intuitive Surgical had a return on equity of 13.62% and a net margin of 26.07%. The company had revenue of $852.10 million during the quarter, compared to analysts’ expectations of $675.15 million. During the same quarter in the previous year, the business earned $3.25 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 7.16 EPS for the current year.

A number of brokerages recently commented on ISRG. BidaskClub upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Friday, July 17th. Bank of America restated a “buy” rating and set a $650.00 target price on shares of Intuitive Surgical in a report on Thursday, April 9th. Raymond James increased their price objective on Intuitive Surgical from $600.00 to $725.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Piper Sandler increased their price objective on Intuitive Surgical from $510.00 to $595.00 and gave the stock a “neutral” rating in a report on Wednesday, July 22nd. They noted that the move was a valuation call. Finally, OTR Global downgraded Intuitive Surgical to a “positive” rating in a report on Tuesday, June 16th. Three analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $660.67.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Stanley Laman Group Ltd. purchased a new position in Intuitive Surgical during the 2nd quarter valued at $330,000. Ellevest Inc. boosted its holdings in Intuitive Surgical by 76.7% during the 2nd quarter. Ellevest Inc. now owns 265 shares of the medical equipment provider’s stock valued at $151,000 after acquiring an additional 115 shares during the period. State of Alaska Department of Revenue raised its position in Intuitive Surgical by 20.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 23,952 shares of the medical equipment provider’s stock valued at $13,648,000 after purchasing an additional 4,037 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in Intuitive Surgical during the 2nd quarter valued at $228,000. Finally, Franklin Resources Inc. raised its position in Intuitive Surgical by 4.3% during the 4th quarter. Franklin Resources Inc. now owns 825,344 shares of the medical equipment provider’s stock valued at $487,898,000 after purchasing an additional 33,827 shares in the last quarter. Institutional investors own 87.24% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Article: Consumer behavior in bull markets

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.